Benefits
Muscle protein synthesis in young adults
In a crossover study in ten healthy young men, about 10 g of beta-lactoglobulin raised muscle protein synthesis after feeding and after a bout of leg exercise, by roughly half over the fasted state. The rise matched an equal amount of whey protein isolate, while beta-lactoglobulin put more leucine and essential amino acids into the blood.
Lean mass and strength gains with resistance training
In an 8-week study, 24 healthy young adults did lower-body resistance training three times a week while taking a recombinant form of beta-lactoglobulin or dairy whey twice daily. Both groups gained leg lean mass (about 0.65 kg) and leg press strength, with no difference between the two proteins. The beta-lactoglobulin tested was a fermentation-made version, not the dairy isolate.
Leucine and essential amino acid delivery
Beta-lactoglobulin is naturally high in leucine, the amino acid most linked to the muscle-building signal, and in branched-chain amino acids. In feeding studies it raised blood leucine and essential amino acids higher than an equal gram amount of standard whey, which is the rationale for using a smaller protein dose to reach the same amino acid trigger.
Muscle amino acid handling during systemic inflammation
In eight young men studied under a short experimental model of inflammation with fasting and bed rest, oral leucine-rich beta-lactoglobulin raised muscle protein synthesis, and the rise was larger under the inflammatory condition than the control. Adding the ketone beta-hydroxybutyrate did not improve overall muscle amino acid balance. This came from one small crossover study.
Postprandial muscle protein synthesis in aged muscle
In a study in old rats, beta-lactoglobulin had the highest leucine content of the milk proteins tested (about 14 percent) and improved muscle protein synthesis after a meal more than lower-leucine proteins, an effect that held over 30 days of feeding. This is animal work; whether it carries over to older people has not been shown in human trials of beta-lactoglobulin.
Mechanism of action
Leucine-driven mTORC1 activation
Beta-lactoglobulin is rich in leucine, which activates the mTORC1 signaling pathway in muscle that turns up the building of new muscle protein after meals and after resistance exercise. This is laboratory mechanism work rather than an outcome measured in the human studies cited here.
Rapid, high amino acid appearance
As a whey fraction, beta-lactoglobulin is digested and absorbed quickly, producing a fast, high peak in blood essential amino acids and leucine. In feeding studies this peak was higher than with an equal amount of ordinary whey, which may let a smaller dose reach the amino acid level that triggers muscle protein synthesis.
High-leucine essential amino acid profile
Beta-lactoglobulin supplies all nine essential amino acids and carries more leucine by weight than most milk proteins, so each gram delivers more of the amino acid that most strongly stimulates muscle protein synthesis.
Clinical trials
Randomized, double-blind crossover acute study using a stable-isotope leucine tracer to measure muscle protein synthesis after beta-lactoglobulin (about 10 g, 1.57 g leucine) or whey protein isolate (about 10 g, 1.02 g leucine), at rest and after one-leg resistance exercise. (Ely et al. 2025, Nutrients)
Ten healthy young men (average age about 26).
Muscle protein synthesis rose significantly after feeding (about 52 percent) and after feeding plus exercise (about 58 percent), with no significant difference between beta-lactoglobulin and whey isolate. Blood leucine, branched-chain and essential amino acids rose higher with beta-lactoglobulin. A co-author worked for Arla Foods Ingredients.
Two-part study: an acute crossover measuring blood amino acids after 0.3 g/kg of recombinant beta-lactoglobulin or dairy whey, and an 8-week double-blind parallel trial pairing twice-daily supplementation with resistance training, measuring DEXA leg lean mass and leg press one-rep max. (Rogers et al. 2025, Med Sci Sports Exerc)
Eight adults in the acute crossover and 24 healthy adults (12 per group, average age about 24) in the training trial.
Blood essential amino acids rose similarly, but blood leucine rose more with recombinant beta-lactoglobulin. After training, leg lean mass (about 0.65 kg) and leg press strength increased in both groups with no significant difference between proteins. The beta-lactoglobulin was a fermentation-made recombinant form, not the dairy isolate.
Randomized crossover study using phenylalanine tracers to measure muscle amino acid balance and synthesis after oral leucine-rich beta-lactoglobulin, with or without beta-hydroxybutyrate, under either an experimental inflammatory, fasting and bed-rest condition or a control condition. (Mose et al. 2021, Am J Clin Nutr)
Eight healthy young men.
Net muscle protein balance rose similarly across all conditions. Beta-lactoglobulin increased muscle protein synthesis more under the inflammatory condition than the control. Adding beta-hydroxybutyrate lowered both synthesis and breakdown but did not improve net balance. A co-author worked for Arla Foods Ingredients.
Animal feeding study comparing milk proteins of differing leucine content (beta-lactoglobulin 14.5 percent down to casein 10 percent) for their effect on postprandial muscle protein synthesis over 30 days. (Rieu et al. 2007, Nutrition)
Sixty rats aged 22 months; an animal study, not people.
The leucine-rich proteins, including beta-lactoglobulin, raised blood leucine and improved muscle protein synthesis after a meal more than lower-leucine proteins, and the effect held over 30 days. An animal study; it was not tested in older people.
Published protocol for a double-blind randomized placebo-controlled trial combining 23 g of beta-lactoglobulin three times daily and resistance training before a period of single-leg immobilisation, with muscle protein synthesis by deuterium oxide tracer as the main measure. (Hughes et al. 2023, Trials)
Planned enrollment of 24 healthy young adults; registered as NCT05496452.
This paper describes the study design only; no results have been published. It is included to show the ingredient is under active investigation, not as evidence of an effect.